<p>SINOPHARM (01099.HK) announced that its subsidiary Sinopharm Accord (000028.SZ) reported for the first three quarters, achieving operating revenue of 55.124 billion RMB (same below), a year-on-year decrease of 2.4%. The net profit attributable to shareholders was 957 million RMB, a decline of 10.2%, with earnings per share of 1.72 RMB</p>

01099

000028

<p>SINOPHARM announced that its subsidiary Sinopharm Accord reported a revenue of RMB 55.124 billion for the first three quarters, a year-on-year decrease of 2.4%. The net profit attributable to shareholders was RMB 957 million, down 10.2%, with earnings per share of RMB 1.72</p>

SINOPHARM's subsidiary Sinopharm Accord earned 957 million RMB in the first three quarters, a decline of 10.2%